The application of expanded noninvasive prenatal screening for genome-wide chromosomal abnormalities and genetic counseling

References

• Shahine L, Lathi R. Recurrent pregnancy loss: evaluation and treatment. Obstet Gynecol Clin North Am. 2015;42(1):117–134.
   PubMed Web of Science ®Google Scholar
• Yilmaz Z, Szatkiewicz JP, Crowley JJ, et al. Exploration of large, rare copy number variants associated with psychiatric and neurodevelopmental disorders in individuals with anorexia nervosa. Psychiatr Genet. 2017;27(4):152–158.
   PubMed Web of Science ®Google Scholar
• Nussbaum R, McInnes R, Willard H. Principles of clinical cytogenetics and genome analysis. In: Thompson MW, Thompson JS, editors. Thompson & Thompson genetics in medicine. 8th ed. Philadelphia, PA: Elsevier; 2016. p. 57–74.
   Google Scholar
• Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350(9076):485–487.
   PubMed Web of Science ®Google Scholar
• Norton ME, Jacobsson B, Swamy GK, et al. Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med. 2015;372(17):1589–1597.
   PubMed Web of Science ®Google Scholar
• Gil MM, Accurti V, Santacruz B, et al. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol. 2017;50(3):302–314.
   PubMed Web of Science ®Google Scholar
• Liang D, Cram DS, Tan H, et al. Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes. Genet Med. 2019;21(9):1998–2006.
   PubMed Web of Science ®Google Scholar
• Gregg AR, Skotko BG, Benkendorf JL, et al. Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics. Genet Med. 2016;18(10):1056–1065.
   PubMed Web of Science ®Google Scholar
• Committee Opinion No. 640. Cell-free DNA screening for fetal aneuploidy. Obstet Gynecol. 2015; 126(3):e31–e37.
   PubMed Web of Science ®Google Scholar
• Ehrich M, Tynan J, Mazloom A, et al. Genome-wide cfDNA screening: clinical laboratory experience with the first 10,000 cases. Genet Med. 2017;19(12):1332–1337.
   PubMed Web of Science ®Google Scholar
• Lefkowitz RB, Tynan JA, Liu T, et al. Clinical validation of a noninvasive prenatal test for genomewide detection of fetal copy number variants. Am J Obstet Gynecol. 2016;215(2):227.e1–e16.
   PubMed Web of Science ®Google Scholar
• Yao H, Gao Y, Zhao J, et al. Genome-wide detection of additional fetal chromosomal abnormalities by cell-free DNA testing of 15,626 consecutive pregnant women. Sci China Life Sci. 2019;62(2):215–224.
   PubMed Web of Science ®Google Scholar
• Jiang F, Ren J, Chen F, et al. Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies. BMC Med Genomics. 2012;5:57.
   PubMed Web of Science ®Google Scholar
• Chitty LS, Hudgins L, Norton ME. Current controversies in prenatal diagnosis 2: cell-free DNA prenatal screening should be used to identify all chromosome abnormalities. Prenat Diagn. 2018;38(3):160–165.
   PubMed Web of Science ®Google Scholar
• Chen Y, Yu Q, Mao X, et al. Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions/microduplications in a cohort of 42,910 single pregnancies with different clinical features. Hum Genomics. 2019;13(1):60.
   PubMed Web of Science ®Google Scholar
• Schwartz S, Kohan M, Pasion R, et al. Clinical experience of laboratory follow-up with noninvasive prenatal testing using cell-free DNA and positive microdeletion results in 349 cases. Prenat Diagn. 2018;38(3):210–218.
   PubMed Web of Science ®Google Scholar
• Rose NC, Kaimal AJ, Dugoff L, et al. Screening for fetal chromosomal abnormalities. Obstet Gynecol. 2020;136(4):e48–e69.
   PubMed Web of Science ®Google Scholar
• Xu HH, Dai MZ, Wang K, et al. A rare Down syndrome foetus with de novo 21q;21q rearrangements causing false negative results in non-invasive prenatal testing: a case report. BMC Med Genomics. 2020;13(1):96.
   PubMed Web of Science ®Google Scholar
• Riegel M, Wisser J, Baumer A, et al. Postzygotic isochromosome formation as a cause for false-negative results from chorionic villus chromosome examinations. Prenat Diagn. 2006;26(3):221–225.
   PubMed Web of Science ®Google Scholar
• Wolstenholme J. An audit of trisomy 16 in man. Prenat Diagn. 1995;15(2):109–121.
   PubMed Web of Science ®Google Scholar
• Chareonsirisuthigul T, Worawichawong S, Parinayok R, et al. Intrauterine growth retardation fetus with trisomy 16 mosaicism. Case Rep Genet. 2014;2014:739513.
   PubMedGoogle Scholar
• Langlois S, Yong SL, Wilson RD, Kwong LC, et al. Prenatal and postnatal growth failure associated with maternal heterodisomy for chromosome 7. J Med Genet. 1995;32(11):871–875.
   PubMed Web of Science ®Google Scholar
• Grati FR, Molina Gomes D, Ferreira JC, et al. Prevalence of recurrent pathogenic microdeletions and microduplications in over 9500 pregnancies. Prenat Diagn. 2015;35(8):801–809.
   PubMed Web of Science ®Google Scholar
• Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature. 2006;444(7118):444–454.
   PubMed Web of Science ®Google Scholar
• American College of O, Gynecologists Committee on G. Committee Opinion No. 545. Noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol. 2012;120(6):1532–1534.
   PubMed Web of Science ®Google Scholar
• Srebniak MI, Joosten M, Knapen M, et al. Frequency of submicroscopic chromosomal aberrations in pregnancies without increased risk for structural chromosomal aberrations: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;51(4):445–452.
   PubMed Web of Science ®Google Scholar
• Crider KS, Olney RS, Cragan JD. Trisomies 13 and 18: population prevalences, characteristics, and prenatal diagnosis, metropolitan Atlanta, 1994-2003. Am J Med Genet A. 2008;146A(7):820–826.
   PubMed Web of Science ®Google Scholar
• Irving C, Richmond S, Wren C, et al. Changes in fetal prevalence and outcome for trisomies 13 and 18: a population-based study over 23 years. J Matern Fetal Neonatal Med. 2011;24(1):137–141.
   PubMed Web of Science ®Google Scholar
• Chen XK, Wen SW, Fleming N, et al. Teenage pregnancy and congenital anomalies: which system is vulnerable? Hum Reprod. 2007;22(6):1730–1735.
   PubMed Web of Science ®Google Scholar
• Khashan AS, Baker PN, Kenny LC. Preterm birth and reduced birthweight in first and second teenage pregnancies: a register-based cohort study. BMC Pregnancy Childbirth. 2010;10(1):36.
   PubMedGoogle Scholar
• Verma IC, Dua-Puri R, Bijarnia-Mahay S. ACMG 2016 update on noninvasive prenatal testing for fetal aneuploidy: implications for India. J Fetal Med. 2017;4(1):1–6.
   Web of Science ®Google Scholar
• Malan V, Bussieres L, Winer N, et al. Effect of cell-free DNA screening vs direct invasive diagnosis on miscarriage rates in women with pregnancies at high risk of Trisomy 21: a randomized clinical trial. JAMA. 2018;320(6):557–565.
   PubMed Web of Science ®Google Scholar
• Salomon LJ, Sotiriadis A, Wulff CB, et al. Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta-analysis. Ultrasound Obstet Gynecol. 2019;54(4):442–451.
   PubMed Web of Science ®Google Scholar